Foley Partner Judith Waltz will be a speaker at the ExL Pharma 11th MSL Best Practices Summit, September 12-13, 2012, held in San Diego, California.
Ms. Waltz will be speaking on September 12, 2012 at the pre-conference workshop on “Regulatory and Legal Risks: A Comprehensive Overview.” At the conference, Ms. Waltz will be part of the Sunshine Panel, a panel of experts who will share their opinions and perspectives on the effects of the provisions in all areas of medical affairs.
The 11th MSL event will provide practical solutions and applications and a better understanding of the full capabilities of the MSL.
People
Related Insights
20 December 2024
Health Care Law Today
GLP-1 Drugs: FDA “Re-Confirms” Decision Removing Tirzepatide from the Drug Shortage List
On December 19, 2024, the U.S. Food and Drug Administration (FDA) issued a Declaratory Order reevaluating and re-confirming that the tirzepatide drug shortage has been resolved. This order revoked and replaced FDA’s October 2, 2024, decision on tirzepatide.
20 December 2024
Manufacturing Industry Advisor
Christmas Came Early: Justice Delivered in Supplier Dispute Over Unjust Enrichment
The AirBoss saga continues… This holiday season, AirBoss Flexible Products Co. received a monumental legal victory, righting a costly wrong in MSSC, Inc. v. AirBoss.
19 December 2024
Health Care Law Today
HIPAA Reproductive Health Care Amendments: Compliance in an Uncertain Enforcement Landscape
The amendments to the HIPAA Privacy Rule designed to protect reproductive health care information are under legal challenge as the compliance date quickly approaches.